Comparison of an administrative algorithm for SLE disease severity to clinical SLE Disease Activity Index scores

Systemic lupus erythematosus (SLE) severity, reflecting both disease intensity and duration, is heterogeneous making it challenging to study in administrative databases where severity may confound or mediate associations with outcomes. Garris et al. developed an administrative claims-based algorithm...

Full description

Saved in:
Bibliographic Details
Published inRheumatology international Vol. 40; no. 2; pp. 257 - 261
Main Authors Speyer, Cameron B., Li, Daniel, Guan, Hongshu, Yoshida, Kazuki, Stevens, Emma, Jorge, April M., Everett, Brendan M., Feldman, Candace H., Costenbader, Karen H.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.02.2020
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0172-8172
1437-160X
1437-160X
DOI10.1007/s00296-019-04477-4

Cover

Abstract Systemic lupus erythematosus (SLE) severity, reflecting both disease intensity and duration, is heterogeneous making it challenging to study in administrative databases where severity may confound or mediate associations with outcomes. Garris et al. developed an administrative claims-based algorithm employing claims over a 1-year period to classify SLE severity as mild, moderate or severe. We sought to compare this administrative algorithm to a measure of SLE activity, the SLE Disease Activity Index-2000 (SLEDAI-2K) score at clinical visits. We identified 100 SLE patients followed in the Brigham and Women’s Hospital (BWH) Lupus Center (in 2008–2010) with SLEDAI-2K scores at each visit over a 1-year period per person. We obtained data for the Garris algorithm for the same year per subject. We compared Garris SLE severity to the highest SLEDAI-2K in that year, with SLEDAI-2K categories of mild < 3, moderate 3–6, and severe > 6. We compared classification using weighted kappa statistics, and positive and negative predictive values (PPV, NPV). We also assessed the binary comparison of mild vs. moderate/severe. We calculated sensitivity, specificity, and McNemar’s test. We analyzed 377 SLEDAI-2K assessments (mean 3.8 [SD 2.6] per subject/year). For classifying moderate/severe vs. mild SLE severity, the sensitivity was 85.7%, specificity 67.6%, PPV 81.8% and NPV 73.5%. The Garris algorithm for classifying SLE severity in administrative datasets had moderate agreement for classification of mild vs. moderate/severe SLE activity assessed by SLEDAI-2K assessments in an academic lupus center. It may be a useful tool for classifying SLE severity in administrative database studies.
AbstractList Systemic lupus erythematosus (SLE) severity, reflecting both disease intensity and duration, is heterogeneous making it challenging to study in administrative databases where severity may confound or mediate associations with outcomes. Garris et al. developed an administrative claims-based algorithm employing claims over a 1-year period to classify SLE severity as mild, moderate or severe. We sought to compare this administrative algorithm to a measure of SLE activity, the SLE Disease Activity Index-2000 (SLEDAI-2K) score at clinical visits. We identified 100 SLE patients followed in the Brigham and Women's Hospital (BWH) Lupus Center (in 2008-2010) with SLEDAI-2K scores at each visit over a 1-year period per person. We obtained data for the Garris algorithm for the same year per subject. We compared Garris SLE severity to the highest SLEDAI-2K in that year, with SLEDAI-2K categories of mild < 3, moderate 3-6, and severe > 6. We compared classification using weighted kappa statistics, and positive and negative predictive values (PPV, NPV). We also assessed the binary comparison of mild vs. moderate/severe. We calculated sensitivity, specificity, and McNemar's test. We analyzed 377 SLEDAI-2K assessments (mean 3.8 [SD 2.6] per subject/year). For classifying moderate/severe vs. mild SLE severity, the sensitivity was 85.7%, specificity 67.6%, PPV 81.8% and NPV 73.5%. The Garris algorithm for classifying SLE severity in administrative datasets had moderate agreement for classification of mild vs. moderate/severe SLE activity assessed by SLEDAI-2K assessments in an academic lupus center. It may be a useful tool for classifying SLE severity in administrative database studies.Systemic lupus erythematosus (SLE) severity, reflecting both disease intensity and duration, is heterogeneous making it challenging to study in administrative databases where severity may confound or mediate associations with outcomes. Garris et al. developed an administrative claims-based algorithm employing claims over a 1-year period to classify SLE severity as mild, moderate or severe. We sought to compare this administrative algorithm to a measure of SLE activity, the SLE Disease Activity Index-2000 (SLEDAI-2K) score at clinical visits. We identified 100 SLE patients followed in the Brigham and Women's Hospital (BWH) Lupus Center (in 2008-2010) with SLEDAI-2K scores at each visit over a 1-year period per person. We obtained data for the Garris algorithm for the same year per subject. We compared Garris SLE severity to the highest SLEDAI-2K in that year, with SLEDAI-2K categories of mild < 3, moderate 3-6, and severe > 6. We compared classification using weighted kappa statistics, and positive and negative predictive values (PPV, NPV). We also assessed the binary comparison of mild vs. moderate/severe. We calculated sensitivity, specificity, and McNemar's test. We analyzed 377 SLEDAI-2K assessments (mean 3.8 [SD 2.6] per subject/year). For classifying moderate/severe vs. mild SLE severity, the sensitivity was 85.7%, specificity 67.6%, PPV 81.8% and NPV 73.5%. The Garris algorithm for classifying SLE severity in administrative datasets had moderate agreement for classification of mild vs. moderate/severe SLE activity assessed by SLEDAI-2K assessments in an academic lupus center. It may be a useful tool for classifying SLE severity in administrative database studies.
Systemic lupus erythematosus (SLE) severity, reflecting both disease intensity and duration, is heterogeneous making it challenging to study in administrative databases where severity may confound or mediate associations with outcomes. Garris et al. developed an administrative claims-based algorithm employing claims over a 1-year period to classify SLE severity as mild, moderate or severe. We sought to compare this administrative algorithm to a measure of SLE activity, the SLE Disease Activity Index-2000 (SLEDAI-2K) score at clinical visits. We identified 100 SLE patients followed in the Brigham and Women’s Hospital (BWH) Lupus Center (in 2008–2010) with SLEDAI-2K scores at each visit over a 1-year period per person. We obtained data for the Garris algorithm for the same year per subject. We compared Garris SLE severity to the highest SLEDAI-2K in that year, with SLEDAI-2K categories of mild < 3, moderate 3–6, and severe > 6. We compared classification using weighted kappa statistics, and positive and negative predictive values (PPV, NPV). We also assessed the binary comparison of mild vs. moderate/severe. We calculated sensitivity, specificity, and McNemar’s test. We analyzed 377 SLEDAI-2K assessments (mean 3.8 [SD 2.6] per subject/year). For classifying moderate/severe vs. mild SLE severity, the sensitivity was 85.7%, specificity 67.6%, PPV 81.8% and NPV 73.5%. The Garris algorithm for classifying SLE severity in administrative datasets had moderate agreement for classification of mild vs. moderate/severe SLE activity assessed by SLEDAI-2K assessments in an academic lupus center. It may be a useful tool for classifying SLE severity in administrative database studies.
Author Jorge, April M.
Yoshida, Kazuki
Feldman, Candace H.
Everett, Brendan M.
Speyer, Cameron B.
Costenbader, Karen H.
Stevens, Emma
Li, Daniel
Guan, Hongshu
AuthorAffiliation 3 Section of Clinical Sciences, Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Hale Building, 6th floor, 60 Fenwood Road, Boston, MA, 02115, USA
1 Section of Clinical Sciences, Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Hale Building, 6th floor, 60 Fenwood Road, Boston, MA, 02115, USA
2 Arthritis Unit, Massachusetts General Hospital, Fruit Street, Boston, MA, 02114, USA
AuthorAffiliation_xml – name: 1 Section of Clinical Sciences, Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Hale Building, 6th floor, 60 Fenwood Road, Boston, MA, 02115, USA
– name: 3 Section of Clinical Sciences, Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Hale Building, 6th floor, 60 Fenwood Road, Boston, MA, 02115, USA
– name: 2 Arthritis Unit, Massachusetts General Hospital, Fruit Street, Boston, MA, 02114, USA
Author_xml – sequence: 1
  givenname: Cameron B.
  surname: Speyer
  fullname: Speyer, Cameron B.
  organization: Section of Clinical Sciences, Division of Rheumatology, Inflammation and Immunity, Brigham and Women’s Hospital
– sequence: 2
  givenname: Daniel
  orcidid: 0000-0003-4293-4509
  surname: Li
  fullname: Li, Daniel
  organization: Section of Clinical Sciences, Division of Rheumatology, Inflammation and Immunity, Brigham and Women’s Hospital
– sequence: 3
  givenname: Hongshu
  surname: Guan
  fullname: Guan, Hongshu
  organization: Section of Clinical Sciences, Division of Rheumatology, Inflammation and Immunity, Brigham and Women’s Hospital
– sequence: 4
  givenname: Kazuki
  surname: Yoshida
  fullname: Yoshida, Kazuki
  organization: Section of Clinical Sciences, Division of Rheumatology, Inflammation and Immunity, Brigham and Women’s Hospital
– sequence: 5
  givenname: Emma
  orcidid: 0000-0002-0338-4439
  surname: Stevens
  fullname: Stevens, Emma
  organization: Section of Clinical Sciences, Division of Rheumatology, Inflammation and Immunity, Brigham and Women’s Hospital
– sequence: 6
  givenname: April M.
  orcidid: 0000-0001-6935-880X
  surname: Jorge
  fullname: Jorge, April M.
  organization: Arthritis Unit, Massachusetts General Hospital
– sequence: 7
  givenname: Brendan M.
  orcidid: 0000-0002-6331-5224
  surname: Everett
  fullname: Everett, Brendan M.
  organization: Section of Clinical Sciences, Division of Rheumatology, Inflammation and Immunity, Brigham and Women’s Hospital
– sequence: 8
  givenname: Candace H.
  surname: Feldman
  fullname: Feldman, Candace H.
  organization: Section of Clinical Sciences, Division of Rheumatology, Inflammation and Immunity, Brigham and Women’s Hospital
– sequence: 9
  givenname: Karen H.
  orcidid: 0000-0002-8972-9388
  surname: Costenbader
  fullname: Costenbader, Karen H.
  email: kcostenbader@bwh.harvard.edu
  organization: Section of Clinical Sciences, Division of Rheumatology, Inflammation and Immunity, Brigham and Women’s Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31784790$$D View this record in MEDLINE/PubMed
BookMark eNqNkU9vEzEQxS1URNPAF-CALHHhsuB_sdcXpCqUtlIkDoDEzfJ6Z1NXu3awdwP59jhNoNBDhQ8eWfN7T-M3Z-gkxAAIvaTkLSVEvcuEMC0rQnVFhFCqEk_QjAquKirJtxM0I1Sxqi7XKTrL-ZaUt5TkGTrlVNVCaTJDm2UcNjb5HAOOHbYB23bwwecx2dFvAdt-HZMfbwbcxYQ_ry5w6zPYDDjDFkpnh8eIXV80zvZ3wIcjcO6Kwx64Di38xNnFBPk5etrZPsOLY52jrx8vviyvqtWny-vl-apyQomxAuLaBhpNpWWk6UAtNOucs6XWzkFrtVOgWUsaBbJjjeigpoxKxyXvtAI-R_zgO4WN3f2wfW82yQ827QwlZp-fOeRnSn7mLj8jiur9QbWZmgFaB6HkcK-M1pt_O8HfmHXcGqkl4VQXgzdHgxS_T5BHM_jsoO9tgDhlwzgjvBa8nDl6_QC9jVMKJZRCFWIhxIIW6tXfE_0Z5fcKC1AfAJdizgk64_xYdhf3A_r-8d-yB9L_iugYbC5wWEO6H_sR1S_0HdI9
CitedBy_id crossref_primary_10_1007_s40744_021_00277_0
crossref_primary_10_1002_acr_24793
crossref_primary_10_1177_0961203321991920
crossref_primary_10_1002_art_42620
crossref_primary_10_1007_s40744_023_00532_6
crossref_primary_10_1177_09612033221146093
crossref_primary_10_1016_j_clinthera_2023_04_013
crossref_primary_10_1016_j_semarthrit_2023_152308
crossref_primary_10_1136_rmdopen_2021_001781
crossref_primary_10_1002_acr2_11424
crossref_primary_10_1136_rmdopen_2021_001586
crossref_primary_10_1093_rap_rkab071
crossref_primary_10_1136_bmjopen_2022_071072
crossref_primary_10_1136_lupus_2022_000750
crossref_primary_10_1177_03000605231225349
crossref_primary_10_1093_rap_rkab061
crossref_primary_10_1080_03007995_2022_2101804
crossref_primary_10_3390_ijerph17249186
crossref_primary_10_1136_lupus_2020_000438
crossref_primary_10_18553_jmcp_2023_29_4_365
crossref_primary_10_1177_09612033251314589
Cites_doi 10.1002/acr.23109
10.11613/BM.2012.031
10.1002/anr.1780320909
10.3111/13696998.2013.778270
10.1093/rheumatology/keh624
10.1037/h0026256
10.1097/EDE.0b013e3181c30fb2
ContentType Journal Article
Copyright Springer-Verlag GmbH Germany, part of Springer Nature 2019
Rheumatology International is a copyright of Springer, (2019). All Rights Reserved.
Copyright_xml – notice: Springer-Verlag GmbH Germany, part of Springer Nature 2019
– notice: Rheumatology International is a copyright of Springer, (2019). All Rights Reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
ADTOC
UNPAY
DOI 10.1007/s00296-019-04477-4
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Proquest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
ProQuest One Academic Middle East (New)

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1437-160X
EndPage 261
ExternalDocumentID oai:pubmedcentral.nih.gov:6960319
PMC6960319
31784790
10_1007_s00296_019_04477_4
Genre Journal Article
Comparative Study
GrantInformation_xml – fundername: National Institute of Arthritis and Musculoskeletal and Skin Diseases
  grantid: R01 AR057327; K24 AR066109; K23 AR071500
  funderid: http://dx.doi.org/10.13039/100000069
– fundername: NIAMS NIH HHS
  grantid: K24 AR066109
– fundername: NIAMS NIH HHS
  grantid: R01 AR057327
– fundername: NCI NIH HHS
  grantid: T32 CA009337
– fundername: NIAMS NIH HHS
  grantid: K23 AR071500
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
123
199
1N0
1SB
2.D
203
28-
29P
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3V.
4.4
406
408
409
40D
40E
53G
5QI
5RE
5VS
67Z
6NX
78A
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
L7B
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
RNS
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z82
Z83
Z87
Z8O
Z8V
Z8W
Z91
ZGI
ZMTXR
ZOVNA
~A9
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PUEGO
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
7X8
5PM
ADTOC
UNPAY
ID FETCH-LOGICAL-c474t-e0cdbeb916a20bfe7592fcca7598cceda9c7e92d0b7e6f2b4fe81216c363f97e3
IEDL.DBID U2A
ISSN 0172-8172
1437-160X
IngestDate Sun Oct 26 04:10:16 EDT 2025
Tue Sep 30 15:38:57 EDT 2025
Thu Oct 02 09:51:51 EDT 2025
Tue Oct 07 06:05:29 EDT 2025
Mon Jul 21 06:01:44 EDT 2025
Thu Apr 24 23:09:05 EDT 2025
Wed Oct 01 04:15:30 EDT 2025
Fri Feb 21 02:39:53 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Administrative
Severity
Systemic lupus erythematosus
Claims data
Algorithm
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c474t-e0cdbeb916a20bfe7592fcca7598cceda9c7e92d0b7e6f2b4fe81216c363f97e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
3. Final approval of the version to be published: Cameron B. Speyer, Daniel Li, Hongshu Guan, Kazuki Yoshida, Emma Stevens, April M. Jorge, Brendan M. Everett, Candace H. Feldman, Karen H. Costenbader
4. Agreement to be accountable for all aspects of the work: Cameron B. Speyer, Daniel Li, Hongshu Guan, Kazuki Yoshida, Emma Stevens, April M. Jorge, Brendan M. Everett, Candace H. Feldman, Karen H. Costenbader
1. Conception of study or data acquisition, analysis and interpretation: Cameron B. Speyer, Daniel Li, Hongshu Guan, Kazuki Yoshida, Emma Stevens, April M. Jorge, Brendan M. Everett, Candace H. Feldman, Karen H. Costenbader
ICJME Criteria for Authorship
2. Drafting the work or revising it critically: Cameron B. Speyer, Daniel Li, Hongshu Guan, Kazuki Yoshida, Emma Stevens, April M. Jorge, Brendan M. Everett, Candace H. Feldman, Karen H. Costenbader
ORCID 0000-0001-6935-880X
0000-0003-4293-4509
0000-0002-6331-5224
0000-0002-8972-9388
0000-0002-0338-4439
OpenAccessLink https://proxy.k.utb.cz/login?url=https://www.ncbi.nlm.nih.gov/pmc/articles/6960319
PMID 31784790
PQID 2343354451
PQPubID 326313
PageCount 5
ParticipantIDs unpaywall_primary_10_1007_s00296_019_04477_4
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6960319
proquest_miscellaneous_2320384333
proquest_journals_2343354451
pubmed_primary_31784790
crossref_citationtrail_10_1007_s00296_019_04477_4
crossref_primary_10_1007_s00296_019_04477_4
springer_journals_10_1007_s00296_019_04477_4
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-02-01
PublicationDateYYYYMMDD 2020-02-01
PublicationDate_xml – month: 02
  year: 2020
  text: 2020-02-01
  day: 01
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Heidelberg
PublicationSubtitle Clinical and Experimental Investigations
PublicationTitle Rheumatology international
PublicationTitleAbbrev Rheumatol Int
PublicationTitleAlternate Rheumatol Int
PublicationYear 2020
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References Petri, Hellmann, Hochberg (CR1) 1992; 19
Steyerberg, Vickers, Cook, Gerds, Gonen, Obuchowski (CR10) 2010; 21
Gladman, Ibanez, Urowitz (CR3) 2002; 29
McHugh (CR9) 2012; 22
Garris, Jhingran, Bass, Engel-Nitz, Riedel, Dennis (CR2) 2013; 16
CR7
Cohen (CR8) 1968; 70
Isenberg, Rahman, Allen, Farewell, Akil, Bruce (CR5) 2005; 44
Liang, Socher, Larson, Schur (CR4) 1989; 32
Polachek, Gladman, Su, Urowitz (CR6) 2017; 69
ML McHugh (4477_CR9) 2012; 22
EW Steyerberg (4477_CR10) 2010; 21
DD Gladman (4477_CR3) 2002; 29
M Petri (4477_CR1) 1992; 19
A Polachek (4477_CR6) 2017; 69
4477_CR7
MH Liang (4477_CR4) 1989; 32
DA Isenberg (4477_CR5) 2005; 44
C Garris (4477_CR2) 2013; 16
J Cohen (4477_CR8) 1968; 70
References_xml – volume: 69
  start-page: 997
  year: 2017
  end-page: 1003
  ident: CR6
  article-title: Defining low disease activity in systemic lupus erythematosus
  publication-title: Arthritis Care Res (Hoboken)
  doi: 10.1002/acr.23109
– volume: 22
  start-page: 276
  year: 2012
  end-page: 282
  ident: CR9
  article-title: Interrater reliability: the kappa statistic
  publication-title: Biochem Med (Zagreb)
  doi: 10.11613/BM.2012.031
– ident: CR7
– volume: 32
  start-page: 1107
  year: 1989
  end-page: 1118
  ident: CR4
  article-title: Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/anr.1780320909
– volume: 29
  start-page: 288
  year: 2002
  end-page: 291
  ident: CR3
  article-title: Systemic lupus erythematosus disease activity index 2000
  publication-title: J Rheumatol
– volume: 16
  start-page: 667
  year: 2013
  end-page: 677
  ident: CR2
  article-title: Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan
  publication-title: J Med Econ
  doi: 10.3111/13696998.2013.778270
– volume: 44
  start-page: 902
  year: 2005
  end-page: 906
  ident: CR5
  article-title: BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keh624
– volume: 70
  start-page: 213
  year: 1968
  end-page: 220
  ident: CR8
  article-title: Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit
  publication-title: Psychol Bull
  doi: 10.1037/h0026256
– volume: 19
  start-page: 53
  year: 1992
  end-page: 59
  ident: CR1
  article-title: Validity and reliability of lupus activity measures in the routine clinic setting
  publication-title: J Rheumatol
– volume: 21
  start-page: 128
  year: 2010
  end-page: 138
  ident: CR10
  article-title: Assessing the performance of prediction models: a framework for traditional and novel measures
  publication-title: Epidemiology
  doi: 10.1097/EDE.0b013e3181c30fb2
– volume: 32
  start-page: 1107
  year: 1989
  ident: 4477_CR4
  publication-title: Arthritis Rheum
  doi: 10.1002/anr.1780320909
– volume: 44
  start-page: 902
  year: 2005
  ident: 4477_CR5
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keh624
– volume: 16
  start-page: 667
  year: 2013
  ident: 4477_CR2
  publication-title: J Med Econ
  doi: 10.3111/13696998.2013.778270
– volume: 22
  start-page: 276
  year: 2012
  ident: 4477_CR9
  publication-title: Biochem Med (Zagreb)
  doi: 10.11613/BM.2012.031
– volume: 69
  start-page: 997
  year: 2017
  ident: 4477_CR6
  publication-title: Arthritis Care Res (Hoboken)
  doi: 10.1002/acr.23109
– volume: 70
  start-page: 213
  year: 1968
  ident: 4477_CR8
  publication-title: Psychol Bull
  doi: 10.1037/h0026256
– ident: 4477_CR7
– volume: 19
  start-page: 53
  year: 1992
  ident: 4477_CR1
  publication-title: J Rheumatol
– volume: 21
  start-page: 128
  year: 2010
  ident: 4477_CR10
  publication-title: Epidemiology
  doi: 10.1097/EDE.0b013e3181c30fb2
– volume: 29
  start-page: 288
  year: 2002
  ident: 4477_CR3
  publication-title: J Rheumatol
SSID ssj0017660
Score 2.3569498
Snippet Systemic lupus erythematosus (SLE) severity, reflecting both disease intensity and duration, is heterogeneous making it challenging to study in administrative...
SourceID unpaywall
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 257
SubjectTerms Adult
Algorithms
Classification
Clinical Coding
Current Procedural Terminology
Databases, Factual
Female
Hospital Information Systems
Humans
International Classification of Diseases
Lupus
Lupus Erythematosus, Systemic - epidemiology
Lupus Erythematosus, Systemic - physiopathology
Lupus Nephritis - epidemiology
Male
Medicine
Medicine & Public Health
Middle Aged
Multi-Institutional Systems
Observational Research
Osteonecrosis - epidemiology
Pleural Effusion - epidemiology
Pleurisy - epidemiology
Rheumatology
Severity of Illness Index
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB6VrcTjgHgVAgUZiRu1yNpOnBwQKmWrgugKAZV6i2zHpkhLsu1mQfx7PF4n7arSikty8ESJM2PP2OP5PoBX6EPGmbQ001lKhakLqr2bpYo7w7iuGSuwUPh4mh-diE-n2ekWTPtaGDxW2c-JYaKuW4N75G8YF5wHOK1383OKrFGYXe0pNFSkVqjfBoixG7DNEBlrBNvvJ9MvX4e8gsxD3TAufGjhL7GMJhTTYYIKV9eYLBBSUrHuqq7Fn9ePUQ651Dtwa9nM1d8_aja74q4O78HdGGeS_ZVh3Ict2zyAm8cxk_4Q5gcDASFpHVENUVdgdH9bomY_fPe7s1_Eh7Xk2-cJibkc4n2pRco70rWkL6wMAh-iwL5ZUVKQjwjFSBaIlLl4BCeHk-8HRzSyL1AjpOioTU2trfbho2KpdlZmJXNe3_5eGGNrVRppS1anWtrcMS2c9cHCODc8566Ulu_AqGkb-wRILYUXq5lLx8pHBLqwqvCe03lJoYx0CYz7H12ZCE2ODBmzagBVDsqpvHKqoJxKJPB6eGa-AubYKL3b66-Kg3RRXZpUAi-HZj-8MGeiGtsuUYalvPByPIHHK3UPr_Ohl_ftZZqAXDOEQQChu9dbmp9nAcI7L5Hdu0xgrzeZy8_a1Iu9waz-o9NPN3f6GdxmuHkQjqDvwqi7WNrnPsLq9Is4bP4BnjUiHw
  priority: 102
  providerName: ProQuest
– databaseName: Unpaywall
  dbid: UNPAY
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fb9MwED6NTuLHAz8HBAYyEm8sXeI4cfJYjU0DsQkBlcpTZDsOq0iTak1B8NdzdpywMmliT4nkL0pOPuu-9u6-A3htYkgYc-3HMg58porUlxhmfRGVikayoDQ1jcInp8nxlL2fxbMtCPteGFu0r-R8XFeLcT0_s7WVy4Xa7-vE9pPMDEbObsB2EuPtCLanpx8nX22pIsfTHdqBTUgDuB8mwcw1yth2OZOCMr-fTTqAce6zzWB0iWFeLpQcsqV34Na6XopfP0VVXQhIR_fgU29KV4fyfbxu5Vj9_kfl8Vq23oe7jp6SSbf0ALZ0_RBunrgE_CNYHgxzC0lTElETcUF994cmovrWnM_bswVBNkw-fzgkLgVEMARrMymPtA3p-zEt4K0DTFQ3yYK8MwqOZGUENlc7MD06_HJw7LuhDb5inLW-DlQhtUTWKWggS83jjJboJnhNldKFyBTXGS0CyXVSUslKjRwjTFSURGXGdfQYRnVT66dACs4QVtAyCAUSCZlqkWLALRHJhOKlB2G_e7lyiuZmsEaVD1rMdsdz3PHc7njOPHgzPLPs9DyuRO_2TpG7s73KacSiyAq7efBqWMZTaVItotbN2mBoEKWIizx40vnQ8DpkbEgJssADvuFdA8Aofm-uoHNY5W_nDx7s9X7497OusmJv8NX_MPrZ9eDP4TY1_0HYSvZdGLXna_0CiVorX7qj-QeBczjv
  priority: 102
  providerName: Unpaywall
Title Comparison of an administrative algorithm for SLE disease severity to clinical SLE Disease Activity Index scores
URI https://link.springer.com/article/10.1007/s00296-019-04477-4
https://www.ncbi.nlm.nih.gov/pubmed/31784790
https://www.proquest.com/docview/2343354451
https://www.proquest.com/docview/2320384333
https://pubmed.ncbi.nlm.nih.gov/PMC6960319
https://www.ncbi.nlm.nih.gov/pmc/articles/6960319
UnpaywallVersion submittedVersion
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1437-160X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017660
  issn: 0172-8172
  databaseCode: AFBBN
  dateStart: 19970301
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 1437-160X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017660
  issn: 0172-8172
  databaseCode: AGYKE
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1437-160X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017660
  issn: 0172-8172
  databaseCode: U2A
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwED-xTYLxgPjcwkZlJN5YpNR24uQxGx3jY9UEVOqeItux2aQuqdYUxH_POU3MqqEJXmJF_uXDOTt39vl-B_DG6ZBhLEwYqzgKuS7TUKGaDSWzmjJVUpq6QOHTcXIy4R-n8bQLClv0u917l2T7p_bBbs6B5Ga_bjGfCxHyDdiKHZ0X9uIJzb3vQCRtbLCb3IQpHrpQmb_fY10d3bIxb2-V9P7Sh_BgWc3lr59yNruhko4fw6POliT5SvhP4J6pnsL9085b_gzmRz7JIKktkRWRN6hyfxgiZ9_r68vm4oqg6Uq-fh6Rzl9DUF8al9aONDXpgydbwLsOkOtV2gnywdEtkoVjw1w8h8nx6NvRSdhlWAg1F7wJTaRLZRSaiJJGyhoRZ9SiTLFMtTalzLQwGS0jJUxiqeLWoEEwTDRLmM2EYS9gs6orswukFBxhJbXRUKLWV6mRKWpHi0gutbABDPsPXeiOftxlwZgVnji5FU6Bwila4RQ8gLf-mvmKfONO9H4vv6IbiIuCMs5Yy8IWwGtfjUPI-UVkZeqlw9CIpYhjAeysxO0fh-YV6u8sCkCsdQQPcPTc6zXV5UVL051kLoN3FsBB32X-vNZdrTjw3eofGv3y_-6-B9vULRi02873YbO5XppXaFU1agAbYioGsJW_P_80wvJwND77MmiHFp5Nxmf5-W9yih5o
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTWLwgPgmMMBI8MQsUtuJk4cJja1Ty9oKwSbtLXMchyGVpNCWaf8cfxtn18lWTap42UvykMuHc2ff2ef7_QDeWh_SiaShUR6FVOgioTm6Wap4qRnPC8YSWyg8HMW9Y_H5JDpZg79NLYzdVtmMiW6gLmpt18g_MC44d3BaHye_qGWNstnVhkJDeWqFYsdBjPnCjkNzcY5TuOlOfx_1_Y6xg-7RXo96lgGqhRQzakJd5CbHMEmxMC-NjFJWYrvwnGhtCpVqaVJWhLk0cclyURp0ip1Y85iXqTQcn3sLNgQXKU7-Nj51R1--tnkMGbs6ZTvRogkefNmOK96zCTE7m7fJCSElFcuu8Vq8e33bZpu7vQub82qiLs7VeHzFPR7ch3s-riW7C0N8AGumegi3hz5z_wgmey3hIalLoiqirsD2_jFEjb_j756d_SQYRpNvgy7xuSOCvttYij0yq0lTyOkE9r3Arl5QYJC-hX4kU4vMOX0MxzeihyewXtWVeQakkALFClaGHYURSJ4YlaCnLlFSKC3LADrNj860h0K3jBzjrAVxdsrJUDmZU04mAnjf3jNZAIGslN5q9Jf5QWGaXZpwAG_ay9idbY5GVaaeWxkW8gTleABPF-puX4ehHsYSaRiAXDKEVsBChS9fqX6cOcjwOLVs4mkA243JXH7WqlZst2b1H41-vrrRr2GzdzQcZIP-6PAF3GF24cJtf9-C9dnvuXmJ0d0sf-W7EIHTm-61_wA8NWGl
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NIQ14QHwTGGAkeGLWUtuJkweEpnXVyj6EBJP6ltmOzZBKUmjKtH-Nv45zvrZqUsXLXpqHXNM6d_b97Lv7HcA770MGkbQ00lFIhckTqtHNUsWdYVznjCW-UPjoON4_EZ8n0WQN_na1MD6tslsT64U6L40_I99mXHBe02ltuzYt4stw9Gn2i_oOUj7S2rXTaEzkwF6c4_Zt_nE8RF2_Z2y09213n7YdBqgRUlTUhibXViNEUizUzsooZQ7HhNfEGJur1EibsjzU0saOaeEsOsRBbHjMXSotx-fegtuS89SnE8pJv9nzvIv1-Q4CBJrgR1uwU5ft-VCY38f7sISQkoplp3gN6V5P2OyjtvfgzqKYqYtzNZ1ecYyjB3C_RbRkpzHBh7Bmi0ewcdTG7B_DbLdvdUhKR1RB1BXC3j-WqOl3fLnV2U-CAJp8PdwjbdSIoNe2vrkeqUrSlXDWAsNWYMc0zS_I2JM-krnn5Jw_gZMb0cJTWC_Kwj4HkkuBYjlz4UAh9tCJVQn6aIeSQhnpAhh0LzozLQm678UxzXr65lo5GSonq5WTiQA-9N-ZNRQgK6U3O_1l7XIwzy6NN4C3_W2cyD46owpbLrwMC3mCcjyAZ426-59DkIcoIg0DkEuG0At4kvDlO8WPs5osPE59H_E0gK3OZC7_1qpRbPVm9R-DfrF60G9gA-dqdjg-PngJd5k_sajz3jdhvfq9sK8Q1lX6dT1_CJze9IT9B466Xz8
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fb9MwED6NTuLHAz8HBAYyEm8sXeI4cfJYjU0DsQkBlcpTZDsOq0iTak1B8NdzdpywMmliT4nkL0pOPuu-9u6-A3htYkgYc-3HMg58porUlxhmfRGVikayoDQ1jcInp8nxlL2fxbMtCPteGFu0r-R8XFeLcT0_s7WVy4Xa7-vE9pPMDEbObsB2EuPtCLanpx8nX22pIsfTHdqBTUgDuB8mwcw1yth2OZOCMr-fTTqAce6zzWB0iWFeLpQcsqV34Na6XopfP0VVXQhIR_fgU29KV4fyfbxu5Vj9_kfl8Vq23oe7jp6SSbf0ALZ0_RBunrgE_CNYHgxzC0lTElETcUF994cmovrWnM_bswVBNkw-fzgkLgVEMARrMymPtA3p-zEt4K0DTFQ3yYK8MwqOZGUENlc7MD06_HJw7LuhDb5inLW-DlQhtUTWKWggS83jjJboJnhNldKFyBTXGS0CyXVSUslKjRwjTFSURGXGdfQYRnVT66dACs4QVtAyCAUSCZlqkWLALRHJhOKlB2G_e7lyiuZmsEaVD1rMdsdz3PHc7njOPHgzPLPs9DyuRO_2TpG7s73KacSiyAq7efBqWMZTaVItotbN2mBoEKWIizx40vnQ8DpkbEgJssADvuFdA8Aofm-uoHNY5W_nDx7s9X7497OusmJv8NX_MPrZ9eDP4TY1_0HYSvZdGLXna_0CiVorX7qj-QeBczjv
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+an+Administrative+Algorithm+for+SLE+Disease+Severity+to+Clinical+SLE+Disease+Activity+Index+Scores&rft.jtitle=Rheumatology+international&rft.au=Speyer%2C+Cameron+B.&rft.au=Li%2C+Daniel&rft.au=Guan%2C+Hongshu&rft.au=Yoshida%2C+Kazuki&rft.date=2020-02-01&rft.issn=0172-8172&rft.eissn=1437-160X&rft.volume=40&rft.issue=2&rft.spage=257&rft.epage=261&rft_id=info:doi/10.1007%2Fs00296-019-04477-4&rft_id=info%3Apmid%2F31784790&rft.externalDocID=PMC6960319
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0172-8172&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0172-8172&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0172-8172&client=summon